Essilor - First-Half 2008 Revenue ( CHARENTON-LE-PONT France July 17...)

Essilor - First-Half 2008 Revenue

Date:7/16/2008

CHARENTON-LE-PONT, France, July 17 /PRNewswire-FirstCall/ --

- First-Half 2008 Revenue Up

- 5.4% Like-for-Like

- 9.6% at Constant Exchange Rates Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR1,520.3 million for the six months ended June 30, 2008, representing a reported 2.9% increase on first half 2007.

Like-for-like growth was 5.4%, in line with trend rates, while growth excluding the currency effect was maintained at a strong 9.6%, lifted by the Company's sustained acquisitions drive (4.2%). This robust performance in a challenging economic environment demonstrates the solid strength of the Company's growth model, built around innovation and acquisitions-led expansion.

As a result, Essilor confirms that the first half will see a further increase in earnings, with operating margin held firm at 2007 levels.

Consolidated revenue for the first six months of 2008

EUR millions First half 2008 First half % change % change

2007 (reported)* (like-for-

like)

Total 1,520.3 1,476.9 + 2.9% + 5.4%

Europe 697.2 675.7 + 3.2% + 2.7%

North America 625.4 622.4 + 0.5% + 7.0%

Asia-Pacific 137.1 128.6 + 6.6% + 6.9%

Latin America 60.6 50.1 + 21.0% + 17.6%

(*) Changes in scope of consolidation added 4.2%; the currency

effect was a negative 6.6%.

First-half like-for-like growth reflected a gain of 6.2% in the first quarter, followed by 4.6%(1) in the second. Note that the year-earlier basis of comparison was high, with like-for-like growth of 8.4% in the first-half and of 8.9% in the second quarter alone.

Of the 4.2% in growth from ch
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Enters Bulgarian Market
4. Essilor : 2007 Results
5. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
6. Essilors 2008 First-Quarter Report
7. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
8. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01 Per Share
11. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million

Post Your Comments:

(Date:12/16/2009)... Md., Dec. 16 For wounded ... Medical Center in Washington, D.C., the holidays can be ... able to travel home rely more than ever on ... This week, calling home just got easier for ... free calling cards, which will provide hundreds of minutes ...

(Date:12/16/2009)... possibly deadly, attack is long-term goal, researchers say ... developed a tool to predict whether a patient will ... first stroke. , "This is an important new tool ... second stroke soon after a first stroke are more ... Ay, of Massachusetts General Hospital and Harvard Medical School, ...

(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...

(Date:12/16/2009)... Ensure and Encourage Access to Quality, Cost-Effective Care , ... ... of Congress have debated the best ways to rein in runaway ... reform. An important part of the ongoing discussion includes how ... care providers besides doctors of medicine (MDs) or osteopathy (DOs). ...

(Date:12/16/2009)... Stress Reduction Therapy or NSRTSM is found very effective in ... as allergies, asthma, migraines, chronic fatigue and a wide array ... country are using this holistic therapy including over 50 branded ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda Health ...

Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2 Health News:New Stroke Tool May Predict Early Recurrence 2 Health News:Behavior modification could ease concerns about nanoparticles 2 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5

[0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital [0] New Stroke Tool May Predict Early Recurrence [0] Behavior modification could ease concerns about nanoparticles [1] Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs [0] BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening

... LOS ANGELES, March 9 /PRNewswire-USNewswire/ -- ... diagnostic imaging center, offers advanced technology that enables ... resulting in better outcomes for patients.On the campus ... Los Angeles Advanced Imaging combines the comforts of ...

... therapies such as radiotherapy, chemotherapy, and retinoic acid (RA). ... prognosis for patients is often poor. However, Vincent Hearing ... National Institutes of Health in Bethesda, Maryland, have now ... to RA, suggesting that this noncytotoxic therapeutic approach may ...

... PRESIDENT AND CEO RESIGNS -ADDISON, Texas, March 9 ULURU ... P. Gray as Chief Executive Officer of the Company effective ... Gray will continue to serve as a Director of the ... of Directors to assume the position of President and Chief ...

... /PRNewswire/ -- SecureWorks(R), one of the ... with Columbian-based ETEK International to extend its security services ... One of South America,s leading security providers, ETEK will ... include, among others, Intrusion Prevention and Detection, Security and ...

... MOUNTAIN VIEW, Calif., March 9 Based on ... market, Frost & Sullivan recognizes ValveXchange, Inc. with ... Innovation of the Year Award for developing the ... two-part bioprosthetic tissue valve, the patented system promises ...

... March 9 ProteoTech Inc. announced today that ... Dr. Luke Esposito, Director of In Vitro Screening, ... Parkinson,s Diseases, to be held in Prague, Czech Republic, March ... Snow will give an oral presentation discussing promising results pertaining ...

Other Medicine News:Health News:L.A.'s Newest Advanced Imaging Center Houses New GE 64-Slice PET/CT and 3T MRI in Spa-Inspired Environment 2 Health News:L.A.'s Newest Advanced Imaging Center Houses New GE 64-Slice PET/CT and 3T MRI in Spa-Inspired Environment 3 Health News:ULURU Inc. Announces Senior Management Change 2 Health News:SecureWorks Partners With ETEK International to Provide Security Services to the South American and Latin American Markets 2 Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 2 Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 3 Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 4 Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 5 Health News:ProteoTech to Present at 9th International Conference for Alzheimer's and Parkinson's Disease - Prague, Czech Republic, March 11-15, 2009 2

L.A.'s Newest Advanced Imaging Center Houses New GE 64-Slice PET/CT and 3T MRI in Spa-Inspired Environment SOX9 renders melanomas sensitive to retinoic acid and stops tumor growth ULURU Inc. Announces Senior Management Change SecureWorks Partners With ETEK International to Provide Security Services to the South American and Latin American Markets Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages ProteoTech to Present at 9th International Conference for Alzheimer's and Parkinson's Disease - Prague, Czech Republic, March 11-15, 2009

(Date:12/16/2009)... December 16 Scientists at,deCODE genetics, Inc. ... the,discovery of a version of a common single-letter ... with a major impact on susceptibility to type ... is not only large, but unusual:,if an individual ... risk of,T2D by more than 30% compared to ...

(Date:12/16/2009)... YORK, December 16 International, ... publication of GFT505 (80 mg/day),data presented ... internationally,recognized expert scientists and clinicians critically ... continuing role of generic lipid-modifying,treatments, fenofibrate ... is commonly observed in patients with ...

(Date:12/16/2009)... RealMed has been ranked the #1 Claims ... Top 20 Best in KLAS Awards: Software ... a dynamic revenue cycle management solution providing ... providers and all payers. KLAS ... vendor performance measurement in the software, professional ...

[0] deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin [0] International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia [0] RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service

... Jan. 25 ,Takeda Pharmaceutical Company Limited (TSE: 4502) and ... has dosed the first patient in,the United States in ... the treatment of anemia in cancer patients undergoing,chemotherapy., ... Affymax are,jointly developing Hematide, and Affymax is now conducting ...

... U.S. Data Highlights Oral Xeloda versus Standard Infusional Chemotherapy ... in Gastroesophageal and Colorectal Cancers -, NUTLEY, ... 33 abstracts involving its oral chemotherapy Xeloda(R) have been,accepted for ... Jan. 25 to 27., Five poster presentations based on ...

Other Medicine Technology:Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia 2 Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia 3 Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 2 Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 3

Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium

Cold light source dual outlet....

The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use....

The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....

... The XL Advantage delivers higher magnification for ... crisp, true image, even at the highest ... edge clarity and precise color rendition is ... with an anti-reflective coating produce a superior ...

Medicine Products:

CM2-150 9100 Head-worn Loupes L XL Advantage 5.5x @ 42cm working distance

Essilor - First-Half 2008 Revenue( CHARENTON-LE-PONT France July 17...),Health